Multi Laboratory Test – AOAC First Action Method 2012.22 Ascorbic Acid (Vitamin C) in Infant Formula and
Adult/Pediatric Nutritionals.
RDLS-RD150006
E. Campos Giménez (NRC, Lausanne)
Page 21
CONFIDENTIAL
The contents of this document constitute a trade secret and the intellectual property rights thereto belong to Nestlé S. A., Vevey, Switzerland.
This document may not be reproduced or disclosed to third parties without prior authorisation.
Annex D: Cover letters to participants
Cover letter:
practice
samples
Continued on next page
Nestlé Research Center
Lausanne
VERS-CHEZ-LES-BLANC
P.O. BOX 44
1000 LAUSANNE 26 (SWITZERLAND)
TEL. +41 (0)21 785 81 11
TELEFAX +41 (0)21 785 89 25
Department Analytical Sciences
Direct Phone +41 21 785 94 29
Direct Fax
+41 21 785 85 53
To :
«Contact_person»
«Laboratory»
«Address»
«City»
«Country»
‡
NRC/AS EsC/
July 30
th
,2014
E. Campos Giménez
Dear participant,
Thank you for your participation in the Stakeholder Panel on Infant Formula and Adult
Nutritionals (SPIFAN) Multi-Laboratory Testing (MLT) for the validation of the AOAC Official
Method
2012.22
“Vitamin C (ascorbic acid) in Infant Formula and Adult/Pediatric Nutritional
Formula by UHPLC-UV”.
We would appreciate it if you could ensure that the contents of the parcel has not been
damaged during transit (see list of contents below), and complete the enclosed “SPIFAN
Practice Samples Receipt Form” and fax or email to Esther Campos Giménez at +41 21 785-
8553 or
esther.campos-gimenez@rdls.nestle.com .The parcel contains the following items:
a) A “SPIFAN Practice Samples Receipt Form” form
b) 2 units of practice samples
Please closely follow the instructions sent to you electronically for the analysis of these
practice samples and data reporting. If you have any questions, do not hesitate to contact the
Study Director for assistance.
Your participation in this Multi-Laboratory Testing study is greatly appreciated.
Yours sincerely,
Sunil Kochhar
Esther Campos Giménez
Analytical Sciences Pillar Head
Study Director
NESTEC LTD
NESTEC LTD
AOAC OMB Meeting Book
355